Company intelligence / Profile preview

PLIVA

Ownership: Private
Development stage: Commercial

Overview

PLIVA has a long history of successful drug development and commercialization. Its most notable achievement was the discovery and patenting of azithromycin in the late 1970s/early '80s. The company has since focused on producing high-quality generic medicines for global markets. It operates as a major exporter with FDA and EMA approvals for its manufacturing standards. Since being acquired by Barr Pharmaceuticals in 2006 and subsequently by Teva Pharmaceutical Industries in late 2008, it serves as Teva’s key generics arm in Central/Eastern Europe.

Therapeutic areas: Men's HealthOtherPsychiatryUrologyInfectious Diseases
Modalities: Small moleculesActive pharmaceutical ingredients (APIs)AntibioticsBiologicalsCytostatics
Industry: Biotech

Drug pipeline

4 assets

azithromycin

Approved

3 more assets in the full pipeline.

Request access →

Partnerships

Pfizer Inc. – licensing agreement for global commercialization of Azithromycin/Zithromax

Beyond the preview

Go deeper on PLIVA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PLIVA.

Explore the full profile